Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Sarcoma × pazopanib × Clear all

Status

Sponsor Class

Study Type

Interventional 33 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 5 Sarcoma 1 Coronary Artery Disease 1

Interventions

Gene Expression Profiling 8 Surveys and Questionnaires 5 Polymerase Chain Reaction 5 Blood Specimen Collection 5 Surgical Procedures, Operative 4 Microarray Analysis 4 Immunohistochemistry 4 Base Sequence 4 Trabectedin 3 Therapeutics 3 Reverse Transcriptase Polymerase Chain Reaction 3 Observation 3 Radiation 2 Psychiatric Rehabilitation 2 In Situ Hybridization, Fluorescence 2 Gene Rearrangement 2 Drug Therapy 2 DNA Methylation 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1 pazopanib 1 liposomal doxorubicin 1 eribulin 1 Watchful Waiting 1 Ropivacaine 1 Referral and Consultation 1 Radiotherapy 1 Radionuclide Imaging 1 Radiation, Ionizing 1 Quality Assurance, Health Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01995981 2017-12-19

PREDICT

Radboud University Medical Center

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡